Cargando…
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry
Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those wi...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362114/ https://www.ncbi.nlm.nih.gov/pubmed/34075574 http://dx.doi.org/10.1111/bjh.17549 |
_version_ | 1783738092007456768 |
---|---|
author | Borjas Howard, Jaime Ruiz‐Sada, Pablo de Leeuw, Karina López‐Jiménez, Luciano Font, Carme Marchena, Pablo Javier Madridano, Olga Debourdeau, Philippe Meijer, Karina Monreal, Manuel |
author_facet | Borjas Howard, Jaime Ruiz‐Sada, Pablo de Leeuw, Karina López‐Jiménez, Luciano Font, Carme Marchena, Pablo Javier Madridano, Olga Debourdeau, Philippe Meijer, Karina Monreal, Manuel |
author_sort | Borjas Howard, Jaime |
collection | PubMed |
description | Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03‐1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks. |
format | Online Article Text |
id | pubmed-8362114 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-83621142021-08-17 Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry Borjas Howard, Jaime Ruiz‐Sada, Pablo de Leeuw, Karina López‐Jiménez, Luciano Font, Carme Marchena, Pablo Javier Madridano, Olga Debourdeau, Philippe Meijer, Karina Monreal, Manuel Br J Haematol Platelets, Haemostasis and Thrombosis Autoimmune disease is a risk factor for first incident venous thromboembolism (VTE). However, data on the risk of recurrent VTE in people with autoimmune disease is sparse. We explored the risk of recurrent VTE using the RIETE registry, comparing people with autoimmune disease (n = 1305) to those without (n = 50608). Overall rates were 6.5 and 5.1 recurrent VTE/100 years for patients with autoimmune disease vs controls, respectively. After adjustment for sex and unprovoked/provoked VTE yielded an adjusted hazard ratio of 1.29 (95%CI 1.03‐1.62). The analysis was limited by short median follow up time (161 days overall), precluding definitive conclusions on recurrent VTE risks. John Wiley and Sons Inc. 2021-06-02 2021-07 /pmc/articles/PMC8362114/ /pubmed/34075574 http://dx.doi.org/10.1111/bjh.17549 Text en © 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Platelets, Haemostasis and Thrombosis Borjas Howard, Jaime Ruiz‐Sada, Pablo de Leeuw, Karina López‐Jiménez, Luciano Font, Carme Marchena, Pablo Javier Madridano, Olga Debourdeau, Philippe Meijer, Karina Monreal, Manuel Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title | Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title_full | Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title_fullStr | Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title_full_unstemmed | Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title_short | Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry |
title_sort | risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the registro informatizado de enfermedad tromboembólica (riete) registry |
topic | Platelets, Haemostasis and Thrombosis |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362114/ https://www.ncbi.nlm.nih.gov/pubmed/34075574 http://dx.doi.org/10.1111/bjh.17549 |
work_keys_str_mv | AT borjashowardjaime riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT ruizsadapablo riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT deleeuwkarina riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT lopezjimenezluciano riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT fontcarme riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT marchenapablojavier riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT madridanoolga riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT debourdeauphilippe riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT meijerkarina riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT monrealmanuel riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry AT riskofrecurrentvenousthromboembolisminpatientswithautoimmunediseasesdatafromtheregistroinformatizadodeenfermedadtromboembolicarieteregistry |